Silk Laser Australia reports a surprisingly good 1HY23 result amidst 4-decade high inflation
Nick Sundich, February 28, 2023
Silk Laser Australia (ASX:SLA) managed to grow its revenues and profit even amidst high inflation. Theoretically, skin laser treatments should be discretionary and that is why its share price has underperformed. The results tell a different story, however.
No time to do stock research, but you still want to invest?
Stocks Down Under Concierge gives you timely BUY and SELL alerts on ASX-listed stocks!
With price targets, buy ranges, stop loss levels and Sell alerts too.
GET A 3-MONTH FREE TRIAL TO CONCIERGE TODAY
Silk Laser Australia grows its revenues and profit
Silk Laser Australia’s network cash sales in 1HY22 increased 35% to $102.8m and revenue grew 21% to $49m. The reason for the discrepancy is that it operates with a franchise model.
The company’s underlying profit increased 15% to $6.6m and its statutory profit rose 22% to $5m. It closed the period with 142 clinics, up from 122 just 6 months earlier, along with $19.4m in cash on the balance sheet.
The average customer spend was $679 and the company’s Net Promoter Score was 80.
But investorsare not giving it credit
Despite Silk Laser Australia’s performance, its shares are down nearly half since its IPO.

Silk Laser Australia (ASX:SLA) share price chart, log scale (Source: TradingView)
The company hasn’t been helped by private equity firm Advent selling roughly half its stake after the IPO. While it retains a 12% stake, there isn’t confidence that it will stick around.
Also not helping its cause have been lockdowns, the Omicron wave and fears that high inflation will cause people (mostly women in the case of this company) to cut back spending on these products.
And even though demand hasn’t decline, it did not grow exponentially either in the way that other retailers experienced.
However, if the company can continue to deliver these results, we think it is inevitable that investors will notice eventually.
Stocks Down Under Concierge gives you timely BUY and SELL alerts on ASX-listed stocks!
With price targets, buy ranges, stop loss levels and Sell alerts too.
GET A 3-MONTH FREE TRIAL TO CONCIERGE TODAY
No credit card needed and the trial expires automatically.
Blog Categories
Get Our Top 5 ASX Stocks for FY25
Recent Posts
Trump vs. Jerome Powell: What Happens to the Market If Powell Is Fired?
The relationship between President Donald Trump and Federal Reserve Chair Jerome Powell has often been tumultuous, particularly around decisions regarding…
Telix Pharmaceuticals (ASX:TLX): It’s made ~A$1.7bn in revenue from Illucix, but here’s why the best is yet to come!
What would you have thought if you were told 5 years ago you would see Telix Pharmaceuticals as a successful…
Anti Woke ETFs: Do they practice what they preach and have they outperformed since Trump’s return to power?
Have you ever heard of so-called ‘Anti Woke ETFs’? If you’re sick of companies that are big on ESG, this…